| Literature DB >> 28181544 |
Elena Eggl1,2, Korbinian Mechlem1,2,3, Eva Braig1,2,3, Stephanie Kulpe1,2, Martin Dierolf1,2, Benedikt Günther1,2,4, Klaus Achterhold1,2, Julia Herzen1,2, Bernhard Gleich2, Ernst Rummeny3, Peter B Noёl1,3, Franz Pfeiffer1,2,3, Daniela Muenzel3.
Abstract
X-ray coronary angiography is an invaluable tool for the diagnosis of coronary artery disease. However, the use of iodine-based contrast media can be contraindicated for patients who present with chronic renal insufficiency or with severe iodine allergy. These patients could benefit from a reduced contrast agent concentration, possibly achieved through application of a mono-energetic x-ray beam. While large-scale synchrotrons are impractical for daily clinical use, the technology of compact synchrotron sources strongly advanced during the last decade. Here we present a quantitative analysis of the benefits a compact synchrotron source can offer in coronary angiography. Simulated projection data from quasi-mono-energetic and conventional x-ray tube spectra is used for a CNR comparison. Results show that compact synchrotron spectra would allow for a significant reduction of contrast media. Experimentally, we demonstrate the feasibility of coronary angiography at the Munich Compact Light Source, the first commercial installation of a compact synchrotron source.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28181544 PMCID: PMC5299841 DOI: 10.1038/srep42211
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(a) Measured MuCLS spectrum at 35 keV peak energy, x-ray tube spectrum at 60 kVp and mass attenuation coefficient of iodine. (b) Simulated iodine-based angiography image for the 60 kVp x-ray tube spectrum. (c) Simulated iodine-based angiography image for the 35 keV MuCLS spectrum.
CNR calculated from simulated projections for two different concentrations of iodine-based contrast media.
| ROI | 60 kVp | 35 keV | gain | 60 kVp | 35 keV | gain |
|---|---|---|---|---|---|---|
| 75 mg/ml iodine | 50 mg/ml iodine | |||||
| 1 | 8.51 ± 0.49 | 9.96 ± 0.36 | 17% | 5.80 ± 0.32 | 7.18 ± 0.26 | 24% |
| 2 | 3.24 ± 0.34 | 3.79 ± 0.19 | 17% | 2.26 ± 0.20 | 2.83 ± 0.23 | 25% |
| 3 | 6.33 ± 0.34 | 7.67 ± 0.38 | 21% | 4.22 ± 0.21 | 5.41 ± 0.12 | 28% |
| 4 | 7.49 ± 0.44 | 9.10 ± 0.47 | 22% | 5.14 ± 0.21 | 6.54 ± 0.27 | 27% |
| 5 | 6.42 ± 0.35 | 7.81 ± 0.22 | 22% | 4.43 ± 0.17 | 5.49 ± 0.23 | 24% |
| 6 | 39.54 ± 1.85 | 29.13 ± 1.07 | −26% | 34.40 ± 1.17 | 27.62 ± 0.61 | −20% |
The standard deviation from the statistical variation of the simulation is given with the mean value of the CNR of the 10 simulation runs.
Figure 2(a) MuCLS spectrum rescaled at 55.8 keV peak energy, x-ray tube spectrum at 90 kVp and mass attenuation coefficient of gadolinium. (b) Simulated gadolinium-based angiography image for the 90 kVp x-ray tube spectrum. (c) Simulated gadolinium-based angiography image for the 55 keV MuCLS spectrum.
CNR calculated from simulated projections for two different concentrations of gadolinium-based contrast media.
| ROI | 90 kVp | 55 keV | gain | 90 kVp | 55 keV | gain |
|---|---|---|---|---|---|---|
| 75 mg/ml gadolinium | 50 mg/ml gadolinium | |||||
| 1 | 5.27 ± 0.18 | 7.42 ± 0.32 | 41% | 3.55 ± 0.17 | 5.01 ± 0.13 | 41% |
| 2 | 1.78 ± 0.41 | 2.87 ± 0.28 | 62% | 1.27 ± 0.30 | 1.65 ± 0.22 | 30% |
| 3 | 3.91 ± 0.15 | 5.57 ± 0.20 | 43% | 2.40 ± 0.17 | 3.62 ± 0.18 | 51% |
| 4 | 4.75 ± 0.15 | 6.75 ± 0.27 | 42% | 3.04 ± 0.21 | 4.53 ± 0.29 | 49% |
| 5 | 3.93 ± 0.17 | 5.69 ± 0.31 | 45% | 2.64 ± 0.20 | 3.77 ± 0.16 | 43% |
| 6 | 30.19 ± 0.95 | 33.83 ± 0.89 | 12% | 24.93 ± 0.55 | 29.45 ± 0.87 | 18% |
The standard deviation from the statistical variation of the simulation is given with the mean value of the CNR of the 10 simulation runs.
Figure 3MuCLS angiography image.
(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX).
Figure 4The Munich Compact Light Source (MuCLS).
(a) Photograph showing the transport line and part of the linear accelerator. (b) Schematic drawing of the laser-electron storage ring. (c) Diagram of inverse Compton scattering (angles exaggerated).
Simulation parameters.
| Contrast Agent | Iodine | Gadolinium |
|---|---|---|
| K-edge energy | 33.17 keV | 50.24 keV |
| X-ray tube | 60 kVp, Tungsten 0.7 mm Cu filter | 90 kVp, Tungsten 0.7 mm Cu filter |
| MuCLS | 35.0 keV peak energy 4% FWHM | 55.0 keV peak energy 4% FWHM |
| Contrast media concentrations | high: 75 mg/mllow: 50 mg/ml | high: 75 mg/mllow: 50 mg/ml |
| Photons in Flatfield (x-ray tube/MuCLS) | 4230/3000 | 15000/15000 |
| Detector sensor | 700 | 700 |
| QE of detector sensor (x-ray tube/MuCLS) | 98.3%/99.5% | 88.2%/97.27% |
| Muscle tissue depth | 3 cm | 10 cm |